Y. Alexander Wu Net Worth

Y. Alexander Wu biography

Dr. Y. Alexander Wu serves as Independent Director of the Company. Dr. Wu has been a director of the Company since April 2013. From 2006 to 2017, Dr. Wu was co- founder and Chief Executive Officer of Crown Bioscience, Inc., a drug discovery and preclinical research organization in the oncology sector with over 600 employees. The company was acquired by JSR for over $400 million in 2017. Before co-founding Crown Bioscience, Dr. Wu was Chief Business Officer of Starvax International Inc., a biopharmaceutical R&D company focusing on the development of novel therapeutic drugs for the treatment of infectious disease and cancer. Prior to Starvax, he was the Head of Asian Operations with Burrill & Company, a life science venture capital and merchant bank. Dr. Wu also co-founded and was Chief Operating Officer of Unimicro Technologies, a life science instrumentation company. He started his career with Hoffmann-La Roche, where he was Manager of Business Development and Strategic Planning. Dr. Wu obtained his B.S. in biochemistry from Fudan University, China, a M.S. in Biochemistry from the University of Illinois, and a Ph.D. in molecular cell biology and MBA from the University of California, Berkeley. Dr. Wu’s experience in the biopharmaceutical industry and research in the oncology and small molecule areas, practical experience as a senior executive operating in U.S. and China, and entrepreneurial vision makes him uniquely qualified to serve as a Director, as well as a member of the Compensation Committee and Audit Committee.

What is the salary of Y Wu?

As the Independent Director of CASI Pharmaceuticals Inc, the total compensation of Y Wu at CASI Pharmaceuticals Inc is $140,450. There are 7 executives at CASI Pharmaceuticals Inc getting paid more, with Wei-Wu He having the highest compensation of $9,269,690.

How old is Y Wu?

Y Wu is 56, he's been the Independent Director of CASI Pharmaceuticals Inc since 2013. There are 7 older and 3 younger executives at CASI Pharmaceuticals Inc. The oldest executive at CASI Pharmaceuticals Inc is Rajesh Shrotriya, 76, who is the Independent Director.

What's Y Wu's mailing address?

Alex's mailing address filed with the SEC is CASI PHARMACEUTICALS, INC., 9620 MEDICAL CENTER DRIVE SUITE 300, ROCKVILLE, MD, 20850.

Insiders trading at CASI Pharmaceuticals Inc

Over the last 12 years, insiders at CASI Pharmaceuticals Inc have traded over $0 worth of CASI Pharmaceuticals Inc stock and bought 30,834,178 units worth $51,898,666 . The most active insiders traders include Wei Wu He, Rajesh C Md Shrotriya und Pharmaceuticals Inc Spectru.... On average, CASI Pharmaceuticals Inc executives and independent directors trade stock every 91 days with the average trade being worth of $6,141,555. The most recent stock trade was executed by James Huang on 6 September 2022, trading 55,573 units of CASI stock currently worth $229,516.

What does CASI Pharmaceuticals Inc do?

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.

CASI Pharmaceuticals Inc executives and stock owners

CASI Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Wei-Wu He,
  Executive Chairman of the Board, Chief Executive Officer
• Alexander Zukiwski,
  Chief Medical Officer
• Wei Zhang,
  President, President of CASI China, Interim Principal Financial Officer
• Dr. Wei-Wu He Ph.D.,
  Chairman & CEO
• Dr. Wei Zhang Ph.D.,
  Pres & Principal Financial Officer
• Dr. Alexander A. Zukiwski M.D.,
  Exec. VP & Chief Medical Officer
• James Huang,
  Independent Director
• Y. Alexander Wu,
  Independent Director
• Franklin Salisbury,
  Independent Director
• Quan Zhou,
  Independent Director
• Rajesh Shrotriya,
  Independent Director
• Amanda Cui,
  VP & Global Controller
• Dr. James E. Goldschmidt Ph.D.,
  Chief Bus. Devel. Officer
• Sara B. Capitelli CPA,
  VP of Fin.
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Ren,
  CEO and Director
• Pharmaceuticals Inc Spectru...,
  
• Alex Wu,
  Director
• Tak W. Mak,
  Director
• China Growth Fund Iii L.P.I...,
  
• Strategy Holding Ltd Wealth,
  10% owner
• Sara B Capitelli,
  VP, Finance & PAO
• George Chi,
  Chief Financial Officer
• Cynthia W. Hu,
  See Remarks
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Keyong Ren,
  Chief Executive Officer
• Larry Zhang,
  President
• Weihao Xu,
  Chief Financial Officer